Latent Pneumocystis carinii infection in commercial rat colonies: comparison of inductive immunosuppressants plus histopathology, PCR, and serology as detection methods.
Histopathologic evaluation combined with a period of immunosuppression has been the standard procedure for detection of Pneumocystis carinii in commercial rat colonies. Variation in induction regimens and in the sensitivity of detection methods may result in underreporting of the presence of P. carinii in breeding colonies or delay its detection. In the present study, methylprednisolone and cyclophosphamide were evaluated for the ability to induce P. carinii infection in rats from an enzootically infected commercial barrier colony. The presence of P. carinii was detected by histopathologic methods and by amplification of a targeted region of the P. carinii thymidylate synthase gene by PCR over the 8-week study period. Sera taken from rats prior to either induction regimen were evaluated for the presence of P. carinii-specific antibodies by the immunoblotting technique. Few significant differences in ability to induce organism burden or in histopathology were observed between the two immunosuppressive regimens. However, a dramatic loss of weight over the study period was observed in rats treated with methylprednisolone but not in rats treated with cyclophosphamide. Although histopathologic changes attributable to P. carinii did not appear before 2 weeks with either immunosuppressant, the presence of the organism in these animals was detected by immunoblotting and PCR. Cyst scores and the intensities of the histopathologic lesions increased during the study period, but the number of rats exhibiting evidence of P. carinii infection did not change after week 3. These results suggest that use of the PCR method on postmortem lung tissue of rats without prior induction regimens or identification of anti-P. carinii antibodies in antemortem serum samples is a sufficiently sensitive method for detection of the presence of a P. carinii carrier state in rodent breeding colonies.
Weisbroth
S H
SH
Anmed/Biosafe, Inc., Rockville, Maryland, USA.
Geistfeld
J
J
Weisbroth
S P
SP
Williams
B
B
Feldman
S H
SH
Linke
M J
MJ
Orr
S
S
Cushion
M T
MT
D000818:Animals; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008168:Lung / Q000473:pathology; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology; D016720:Pneumocystis Infections / Q000175:diagnosis* / Q000473:pathology; D016133:Polymerase Chain Reaction; D051381:Rats; D011916:Rats, Inbred F344; D012698:Serologic Tests
D007166:Immunosuppressive Agents; D008775:Methylprednisolone